We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+9.67%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$42.6B
AUM Growth
-$927M
(-2.1%)
Cap. Flow
-$4.42B
Cap. Flow
% of AUM
-10.38%
Top 10 Holdings %
Top 10 Hldgs %
9.02%
Holding
3,518
New
408
Increased
1,022
Reduced
1,392
Closed
532
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$244M |
| 2 |
Pfizer
PFE
|
+$234M |
| 3 |
Nike
NKE
|
+$201M |
| 4 |
Tesla
TSLA
|
+$200M |
| 5 |
S&P Global
SPGI
|
+$196M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$305M |
| 2 |
Advanced Micro Devices
AMD
|
+$241M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$231M |
| 4 |
Merck
MRK
|
+$199M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Healthcare | 11.63% |
| 3 | Consumer Discretionary | 11.09% |
| 4 | Financials | 10.76% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Collegium Pharmaceutical
COLL
$956M
| $8.77M | 0.02% |
225,806
-34,006
| -13% | -$1.19M |
|
677
Ameriprise Financial
AMP
$48.8B
| $8.75M | 0.02% |
19,953
-10,718
| -35% | -$4.29M |
|
678
UWM Holdings
UWMC
$434M
| $8.73M | 0.02% |
1,203,114
+716,700
| +147% | +$4.84M |
|
679
Enphase Energy
ENPH
$5.53B
| $8.68M | 0.02% |
+71,757
| New | +$8.37M |
|
680
Hayward Holdings
HAYW
$3.36B
| $8.66M | 0.02% |
565,602
-112,744
| -17% | -$1.51M |
|
681
Xylem
XYL
$28.1B
| $8.65M | 0.02% |
66,932
+18,601
| +38% | +$2.25M |
|
682
Main Street Capital
MAIN
$5.48B
| $8.64M | 0.02% |
182,561
-179,474
| -50% | -$8.11M |
|
683
GXO Logistics
GXO
$5.55B
| $8.6M | 0.02% |
+159,909
| New | +$8.64M |
|
|
GMS
684
DELISTED
GMS Inc
GMS
| $8.57M | 0.02% |
87,999
-16,048
| -15% | -$1.4M |
|
685
State Street Industrial Select Sector SPDR ETF
XLI
$33.7B
| $8.55M | 0.02% |
67,840
+20,230
| +42% | +$2.38M |
|
686
Allogene Therapeutics
ALLO
$694M
| $8.54M | 0.02% |
1,911,338
-403,203
| -17% | -$1.68M |
|
|
QVCGA
687
DELISTED
QVC Group Inc Series A
QVCGA
| $8.54M | 0.02% |
138,834
-16,509
| -11% | -$863K |
|
688
Kennametal
KMT
$2.52B
| $8.53M | 0.02% |
342,146
-186,170
| -35% | -$4.58M |
|
689
Vanguard S&P 500 Growth ETF
VOOG
$27.2B
| $8.5M | 0.02% |
167,400
-20,400
| -11% | -$985K |
|
|
PPLI
690
People Inc
PPLI
$3.1B
| $8.48M | 0.02% |
193,839
+162,486
| +518% | +$7.01M |
|
691
Penske Automotive Group
PAG
$14.2B
| $8.47M | 0.02% |
52,271
+41,218
| +373% | +$6.29M |
|
692
Janux Therapeutics
JANX
$967M
| $8.46M | 0.02% |
224,720
+180,612
| +409% | +$3.93M |
|
693
Pebblebrook Hotel Trust
PEB
$2.05B
| $8.43M | 0.02% |
547,043
+368,361
| +206% | +$5.8M |
|
694
Element Solutions
ESI
$9.23B
| $8.4M | 0.02% |
336,337
+252,837
| +303% | +$5.88M |
|
695
Weyerhaeuser
WY
$18.4B
| $8.37M | 0.02% |
233,132
+107,741
| +86% | +$3.65M |
|
696
Innoviva
INVA
$1.48B
| $8.37M | 0.02% |
549,226
+178,312
| +48% | +$2.8M |
|
697
World Kinect Corp
WKC
$1.86B
| $8.37M | 0.02% |
316,389
-145,673
| -32% | -$3.46M |
|
|
PINC
698
DELISTED
Premier
PINC
| $8.37M | 0.02% |
378,562
-15,744
| -4% | -$341K |
|
|
TPH
699
DELISTED
Tri Pointe Homes
TPH
| $8.31M | 0.02% |
215,054
+134,404
| +167% | +$4.71M |
|
700
Clear Secure
YOU
$5.28B
| $8.31M | 0.02% |
390,850
+340,511
| +676% | +$6.77M |
|
Similar funds
VAM
Two Sigma Investments's Q1 2024 Portfolio in Review
As of Q1 2024, Two Sigma Investments held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Two Sigma Investments withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Two Sigma Investments opened a new position in Pfizer worth $234M.
- Two Sigma Investments's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
- Two Sigma Investments added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
- Two Sigma Investments's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
- Two Sigma Investments fully exited Rivian in Q1 2024, selling an estimated $158M.
- Two Sigma Investments's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
- Two Sigma Investments opened 408 new positions and closed 532 in Q1 2024.
- Two Sigma Investments's portfolio value fell 2.1% quarter-over-quarter to $42.6B.
Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.